Bank of New York Mellon
OREX

Bank of New York Mellon’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Bank of New York Mellon’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-14,721
Closed -$19K – 4516
2017
Q4 		$19K Sell
14,721
-1
-0% -$2 ﹤0.01% 4305
2017
Q3 		$31K Buy
14,722
+1
+0% +$2 ﹤0.01% 4178
2017
Q2 		$43K Sell
14,721
-4,275
-23% -$12.8K ﹤0.01% 4154
2017
Q1 		$66K Buy
18,996
+4,002
+27% +$15.8K ﹤0.01% 4103
2016
Q4 		$26K Sell
14,994
-691
-4% -$1.62K ﹤0.01% 4197
2016
Q3 		$52K Sell
15,685
-2,764
-15% -$10.4K ﹤0.01% 4134
2016
Q2 		$79K Sell
18,449
-38,276
-67% -$173K ﹤0.01% 4103
2016
Q1 		$320K Buy
56,725
+208
+0.4% +$2.7K ﹤0.01% 3623
2015
Q4 		$972K Buy
56,517
+4,040
+8% +$96.3K ﹤0.01% 3183
2015
Q3 		$1.11M Sell
52,477
-21,509
-29% -$737K ﹤0.01% 3119
2015
Q2 		$3.66M Sell
73,986
-5,444
-7% -$325K ﹤0.01% 2553
2015
Q1 		$6.22M Buy
79,430
+2,701
+4% +$168K ﹤0.01% 2197
2014
Q4 		$4.65M Buy
76,729
+2,167
+3% +$109K ﹤0.01% 2348
2014
Q3 		$3.18M Buy
74,562
+8,809
+13% +$473K ﹤0.01% 2577
2014
Q2 		$4.06M Buy
65,753
+7,650
+13% +$445K ﹤0.01% 2438
2014
Q1 		$3.78M Buy
58,103
+8,801
+18% +$595K ﹤0.01% 2459
2013
Q4 		$2.78M Sell
49,302
-7,700
-14% -$433K ﹤0.01% 2671
2013
Q3 		$3.49M Buy
57,002
+7,885
+16% +$534K ﹤0.01% 2468
2013
Q2 		$2.87M Buy
+49,117
New +$3.02M ﹤0.01% 2550

Other funds holding OREX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
OWIM
Old West Investment Management Los Angeles, California $944M AUM 90.26% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of New York Mellon's OREX Position: Q1 2018 in Review

Bank of New York Mellon sold out of Orexigen Therapeutics, Inc. (OREX) in Q1 2018, closing a stake of 14,721 shares — an estimated $19K sold.

Bank of New York Mellon first reported a position in OREX in Q2 2013 and held it in 19 quarters. The position peaked at $6.22M in Q1 2015. 27 funds tracked by Wall St. Rank hold OREX as of Q1 2018.

  • Bank of New York Mellon reported no remaining Orexigen Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Bank of New York Mellon sold 14,721 Orexigen Therapeutics, Inc. shares in Q1 2018, an estimated $19K.
  • Bank of New York Mellon first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and held it in 19 quarters.
  • Bank of New York Mellon's Orexigen Therapeutics, Inc. position peaked at $6.22M in Q1 2015.
  • 27 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q1 2018.

Based on Bank of New York Mellon's 13F filing for Q1 2018, filed 15 May 2018.